Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2025-12-25 @ 12:20 PM
NCT ID:
NCT04338061
Group ID:
EG001
Title:
Evobrutinib
Description:
Participants received Evobrutinib at a dose of 45 mg orally twice daily up to 156 weeks in Double blind treatment period (DBTP) followed by twice daily oral doses of Evobrutinib 45 mg up to 96 weeks in double blind extension (DBE) period.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
51
Serious Number At Risk:
581
Other Number Affected:
409
Other Number At Risk:
581
Study:
NCT04338061
Results Section:
NCT04338061
Adverse Events Module:
NCT04338061